Farmers & Merchants Investments Inc Amgen Inc Transaction History

Farmers & Merchants Investments Inc

  • $3.19 Billion
  • Q3 2024

A detailed history of Farmers & Merchants Investments Inc transactions in Amgen Inc stock. As of the latest transaction made, Farmers & Merchants Investments Inc holds 25,538 shares of AMGN stock, worth $6.81 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
25,538
Previous 26,288 2.85%
Holding current value
$6.81 Million
Previous $8.21 Million 0.18%
% of portfolio
0.26%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$309.38 - $337.38 $232,035 - $253,035
-750 Reduced 2.85%
25,538 $8.23 Million
Q2 2024

Aug 05, 2024
BUY
$262.75 - $319.31 $19,706 - $23,948
75 Added 0.29%
26,288 $8.21 Million
Q1 2024

Apr 18, 2024
SELL
$268.87 - $324.56 $29,575 - $35,701
-110 Reduced 0.42%
26,213 $7.45 Million
Q4 2023

Jan 23, 2024
SELL
$255.7 - $288.46 $36,565 - $41,249
-143 Reduced 0.54%
26,323 $7.58 Million
Q3 2023

Oct 25, 2023
SELL
$218.65 - $271.46 $69,312 - $86,052
-317 Reduced 1.18%
26,466 $7.11 Million
Q2 2023

Aug 01, 2023
SELL
$214.27 - $253.37 $91,921 - $108,695
-429 Reduced 1.58%
26,783 $5.95 Million
Q1 2023

May 12, 2023
SELL
$225.79 - $275.2 $891,644 - $1.09 Million
-3,949 Reduced 12.67%
27,212 $6.58 Million
Q4 2022

Feb 02, 2023
SELL
$229.03 - $291.01 $54,967 - $69,842
-240 Reduced 0.76%
31,161 $8.18 Million
Q3 2022

Oct 31, 2022
BUY
$224.46 - $253.15 $20,201 - $22,783
90 Added 0.29%
31,401 $7.08 Million
Q2 2022

Jul 28, 2022
SELL
$230.71 - $256.74 $4,614 - $5,134
-20 Reduced 0.06%
31,311 $7.62 Million
Q1 2022

Apr 19, 2022
SELL
$219.27 - $242.57 $190,326 - $210,550
-868 Reduced 2.7%
31,331 $7.58 Million
Q4 2021

Jan 14, 2022
BUY
$198.88 - $227.6 $1.96 Million - $2.24 Million
9,856 Added 44.11%
32,199 $7.24 Million
Q3 2021

Oct 21, 2021
SELL
$212.27 - $248.7 $1.27 Million - $1.49 Million
-5,983 Reduced 21.12%
22,343 $4.75 Million
Q2 2021

Jul 16, 2021
SELL
$233.58 - $259.14 $118,425 - $131,383
-507 Reduced 1.76%
28,326 $6.9 Million
Q1 2021

Apr 14, 2021
SELL
$221.91 - $258.6 $222,131 - $258,858
-1,001 Reduced 3.36%
28,833 $7.17 Million
Q4 2020

Jan 20, 2021
BUY
$216.38 - $257.67 $432,760 - $515,340
2,000 Added 7.19%
29,834 $6.86 Million
Q3 2020

Oct 19, 2020
SELL
$234.65 - $260.95 $5,162 - $5,740
-22 Reduced 0.08%
27,834 $7.07 Million
Q2 2020

Jul 21, 2020
BUY
$197.81 - $242.74 $396,411 - $486,450
2,004 Added 7.75%
27,856 $6.57 Million
Q1 2020

Apr 16, 2020
SELL
$182.24 - $241.7 $364 - $483
-2 Reduced 0.01%
25,852 $5.24 Million
Q4 2019

Jan 21, 2020
BUY
$189.21 - $243.2 $946 - $1,216
5 Added 0.02%
25,854 $6.23 Million
Q3 2019

Oct 18, 2019
SELL
$174.11 - $208.62 $17,411 - $20,862
-100 Reduced 0.39%
25,849 $5 Million
Q2 2019

Jul 24, 2019
BUY
$166.7 - $195.41 $2,833 - $3,321
17 Added 0.07%
25,949 $4.78 Million
Q1 2019

Apr 26, 2019
SELL
$180.87 - $203.88 $7,958 - $8,970
-44 Reduced 0.17%
25,932 $4.93 Million
Q4 2018

Jan 24, 2019
BUY
$178.4 - $208.25 $177,686 - $207,417
996 Added 3.99%
25,976 $5.06 Million
Q3 2018

Oct 30, 2018
SELL
$185.29 - $208.89 $24,087 - $27,155
-130 Reduced 0.52%
24,980 $5.18 Million
Q2 2018

Jul 23, 2018
SELL
$166.05 - $186.51 $89,500 - $100,528
-539 Reduced 2.1%
25,110 $4.64 Million
Q1 2018

Apr 17, 2018
SELL
$169.43 - $198.0 $49,981 - $58,410
-295 Reduced 1.14%
25,649 $4.37 Million
Q4 2017

Jan 26, 2018
SELL
$168.79 - $188.59 $28,525 - $31,871
-169 Reduced 0.65%
25,944 $4.51 Million
Q3 2017

Oct 19, 2017
BUY
$167.29 - $191.0 $4.37 Million - $4.99 Million
26,113
26,113 $4.87 Million

Others Institutions Holding AMGN

# of Institutions
3,126
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $143B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Farmers & Merchants Investments Inc Portfolio

Follow Farmers & Merchants Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers & Merchants Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Farmers & Merchants Investments Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email